Web-Based Interface

 

 

Accessed via an easy-to-use, intuitive user interface, Pharmaview provides objective, invaluable analysis and insight into the biopharmaceutical industry.
 

Therapy Analysis

With all relevant information grouped by therapy area, our Therapy Analysis provides access to key therapeutic events, disease area overviews and therapy area rankings by company. In addition, product portfolios and sales forecasts can be viewed by individual therapeutic class and by individual companies participating in a specific therapy area. This includes:

• Insightful and in-depth qualitative analysis on more than 2,100 drugs from more than 250 companies
• Transparent forecasts and assumptions for more than 1,200 brands, in 150 product classes, across 14 therapy areas, providing insight into which therapies are predicted to drive future growth in the pharmaceutical industry
• Analysis of the current state of key therapeutic areas, together with the likely strategic development plans for each participating company
• Monthly updates on therapy area events that help users stay on top of key issues

Company Analysis

Updated on an ongoing basis with the latest news and analysis, our Company Analysis provides independent and objective insight into the strategy and business development activities of the leading pharmaceutical and biotechnology companies. This includes:

• Corporate, geographic, therapeutic and business development strategies
• Coverage of major strategic moves and product/technology deals
• Details of leading marketed products and franchises including historic sales data and independent 7-year forecasts by company
• Coverage of key R&D candidates and pipelines
• Insight into factors affecting the future prospects for specific products and R&D candidates
• Monthly updates tracking and analyzing major company events

Industry Analysis

Providing up-to-date analysis and insight into the industry-wide and territory-specific issues shaping the pharmaceutical industry, our Industry Analysis helps busy executives cut through the news flow and understand the impact of key events. This includes:

• Concise and comparable analysis, together with key reference data and ready-to-use graphics, focusing on the healthcare/pharmaceutical business environment in the G7 and emerging markets
• Monthly event reports covering key industry developments and their potential impact on the global pharmaceutical and biotechnology markets
• Background reports provide summaries of the structure and key features of each country’s healthcare and pharmaceutical market
• Industry rankings of companies, products and therapy areas
• Thought leadership from a team of career experienced analysts and consultants—delivering intelligent and objective viewpoints on the issues that matter